Drug shortage
Methylprednisolone Acetate Injection · Eugia US LLC
FDA drug shortage · Current · updated Oct 2, 2026
Key facts
| Generic name | Methylprednisolone Acetate Injection |
|---|---|
| Company | Eugia US LLC |
| Presentation | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Rheumatology |
| Package NDCs | 55150-314-01 |
| First posted | Dec 15, 2021 |
| Last updated | Oct 2, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: